Literature DB >> 25400826

¹⁸F-fluorodeoxyglucose PET/CT features and correlations with histopathologic characteristics in sclerosing epithelioid fibrosarcoma.

Yaping Luo1, Wendi Hu2, Huanwen Wu3, Huadan Xue4, Li Huo1, Fang Li1, Yupei Zhao2, Menghua Dai2.   

Abstract

Sclerosing epithelioid fibrosarcoma (SEF) is a clinicopathologically distinct variant of fibrosarcoma that is capable of recurrence and metastasis. Awareness of imaging features and histopathologic characteristics will be helpful for differential diagnosis from other common tumors. Here, we report a case of SEF metastasizing to the pancreas as a solitary mass mimicking primary pancreatic cancer, and summarize the reported cases with FDG PET/CT from the literature (n=4). PET/CT showed abnormal FDG accumulation (n=2), mild FDG uptake (n=1), or photopenic (n=1). The FDG PET/CT features are closely related to histopathologic characteristics regarding its differentiation and aggressiveness.

Entities:  

Keywords:  FDG; PET/CT; Sclerosing epitheloid fibrosarcoma; pancreas

Mesh:

Substances:

Year:  2014        PMID: 25400826      PMCID: PMC4230054     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  44 in total

1.  A rare tumour in the pelvis presenting with lower urinary symptoms: 'sclerosing epithelioid fibrosarcoma'.

Authors:  M Arya; F Garcia-Montes; H R Patel; M Emberton; A R Mundy
Journal:  Eur J Surg Oncol       Date:  2001-02       Impact factor: 4.424

2.  Whole-body metabolic tumour volume of 18F-FDG PET/CT improves the prediction of prognosis in small cell lung cancer.

Authors:  Jong-Ryool Oh; Ji-Hyoung Seo; Ari Chong; Jung-Joon Min; Ho-Chun Song; Young-Chul Kim; Hee-Seung Bom
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-01-21       Impact factor: 9.236

3.  [Sclerosing epithelioid fibrosarcoma].

Authors:  L Boudová; M Michal; Z Kinkor; V Bencík; K Husek; P Mukensnabl; M Rousarová
Journal:  Cesk Patol       Date:  2001-11

4.  Overexpression of MDM2 in a sclerosing epithelioid fibrosarcoma: genetic, immunohistochemical and ultrastructural study of a case.

Authors:  Yu-Fei Jiao; Shin-ichi Nakamura; Tamotsu Sugai; Noriyuki Uesugi; Wataru Habano; Masaya Ogata; Tomoaki Fujioka
Journal:  Pathol Int       Date:  2002-02       Impact factor: 2.534

5.  CPT-11 Chemotherapy Rescued A Patient with Atypical Sclerosing Epithelioid Fibrosarcoma from Emergent Condition.

Authors:  Chun-Hua Pan; Xi-Qun Han; Jian-Sheng Li
Journal:  Chin J Cancer Res       Date:  2012-09       Impact factor: 5.087

6.  Tumor Burden Assessed by the Maximum Standardized Uptake Value and Greatest Diameter on FDG-PET Predicts Prognosis in Untreated Diffuse Large B-cell Lymphoma.

Authors:  Xuan Canh Nguyen; Won Woo Lee; Amr Mohamed Amin; Jae Seon Eo; Soo-Mee Bang; Jong Seok Lee; Sang Eun Kim
Journal:  Nucl Med Mol Imaging       Date:  2010-02-26

7.  [Sclerosing epithelioid fibrosarcoma: a clinicopathologic study of eight cases].

Authors:  Wei-wei Hu; Ri-quan Lai; Jian Wang; Xiao-dong Feng; Guang-min Li
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  2004-08

8.  Sclerosing epithelioid fibrosarcoma of the cecum: a radiation-associated tumor in a previously unreported site.

Authors:  Jared C Frattini; Julie Ann Sosa; Susanne Carmack; Marie E Robert
Journal:  Arch Pathol Lab Med       Date:  2007-12       Impact factor: 5.534

9.  Sclerosing epithelioid fibrosarcoma of the liver infiltrating the inferior vena cava.

Authors:  Yoshito Tomimaru; Hiroaki Nagano; Shigeru Marubashi; Shogo Kobayashi; Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Toru Kitagawa; Koji Umeshita; Nobuyuki Hashimoto; Hideki Yoshikawa; Kenichi Wakasa; Yuichiro Doki; Masaki Mori
Journal:  World J Gastroenterol       Date:  2009-09-07       Impact factor: 5.742

10.  Sclerosing epithelioid fibrosarcoma as a rare cause of ascites in a young man: a case report.

Authors:  Philip J Smith; Beverley Almeida; Jasna Krajacevic; Barry Taylor
Journal:  J Med Case Rep       Date:  2008-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.